Evidence map›Paper›PMID 29789507›Full record

Trial reportNutrients2018

Acute Caffeinated Coffee Consumption Does not Improve Time Trial Performance in an 800-m Run: A Randomized, Double-Blind, Crossover, Placebo-Controlled Study.

Alexandre C Marques, Alison A Jesus, Bruna M Giglio, Ana C Marini, Patrícia C B Lobo, João F Mota, Gustavo D Pimentel

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. International society of sports nutrition position stand: coffee and sports performance.Journal of the International Society of Sports Nutrition · 2023
    Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Caffeine and Exercise: What Next?Sports medicine (Auckland, N.Z.) · 2019
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Alexandre C MarquesClinical and Sports Nutrition Research Laboratory (Labince), Faculty of Nutrition, Federal University of Goias, Goiânia, GO 74605-080, Brazil. alexandre.c.marques@hotmail.com.
Alison A JesusClinical and Sports Nutrition Research Laboratory (Labince), Faculty of Nutrition, Federal University of Goias, Goiânia, GO 74605-080, Brazil. alison_deus@hotmail.com.
Bruna M GiglioClinical and Sports Nutrition Research Laboratory (Labince), Faculty of Nutrition, Federal University of Goias, Goiânia, GO 74605-080, Brazil. brunamgiglio@gmail.com.
Ana C MariniClinical and Sports Nutrition Research Laboratory (Labince), Faculty of Nutrition, Federal University of Goias, Goiânia, GO 74605-080, Brazil. ac.marini22@gmail.com.
Patrícia C B LoboClinical and Sports Nutrition Research Laboratory (Labince), Faculty of Nutrition, Federal University of Goias, Goiânia, GO 74605-080, Brazil. patriciacristina.nutri@gmail.com.ORCID 0000-0001-6123-7616
João F MotaClinical and Sports Nutrition Research Laboratory (Labince), Faculty of Nutrition, Federal University of Goias, Goiânia, GO 74605-080, Brazil. jfemota@gmail.com.
Gustavo D PimentelClinical and Sports Nutrition Research Laboratory (Labince), Faculty of Nutrition, Federal University of Goias, Goiânia, GO 74605-080, Brazil. gupimentel@yahoo.com.br.ORCID 0000-0002-2979-9819

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionStudies evaluating caffeinated coffee (CAF) can reveal ergogenic effects; however, studies on the effects of caffeinated coffee on running are scarce and controversial.

aimTo investigate the effects of CAF consumption compared to decaffeinated coffee (DEC) consumption on time trial performances in an 800-m run in overnight-fasting runners.

methodsA randomly counterbalanced, double-blind, crossover, placebo-controlled study was conducted with 12 healthy adult males with experience in amateur endurance running. Participants conducted two trials on two different occasions, one day with either CAF or DEC, with a one-week washout. After arriving at the data collection site, participants consumed the soluble CAF (5.5 mg/kg of caffeine) or DEC and after 60 min the run was started. Before and after the 800-m race, blood pressure and lactate and glucose concentrations were measured. At the end of the run, the ratings of perceived exertion (RPE) scale was applied.

resultsThe runners were light consumers of habitual caffeine, with an average ingestion of 91.3 mg (range 6⁻420 mg/day). Time trial performances did not change between trials (DEF: 2.38 + 0.10 vs. CAF: 2.39 + 0.09 min,

conclusionCAF consumption failed to enhance the time trial performance of an 800-m run in overnight-fasting runners, when compared with DEC ingestion. In addition, no change was found in RPE, blood pressure levels, or blood glucose and lactate concentrations between the two trials.

Indexed as

Athletic PerformanceCoffeeRunningAdultBiomarkersBlood GlucoseBlood PressureBrazilCaffeineCentral Nervous System StimulantsCross-Over StudiesDouble-Blind MethodHumansLactic AcidMaleTask Performance and AnalysisBiomarkersBlood GlucoseCaffeineCentral Nervous System StimulantsCoffeeLactic Acidcaffeinecoffeeperformanceruntime trial

Identifiers

PMID29789507
PMCPMC6024787

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.